Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.
作者： Peter K Sch??dlich , Caroline Schmidt-Lucke , Eduard Huppertz , Walter Lehmacher , Uwe Nixdorff
DOI: 10.2165/00129784-200707030-00006
关键词:
摘要: Objective To estimate, from the perspective of Statutory Health Insurance (SHI, third-party payer) in Germany, economic consequences using subcutaneous low-molecular-weight heparin (LMWH) enoxaparin instead intravenous unfractionated followed by oral phenprocoumon (UFH/PPC) for anticoagulation patients undergoing transesophageal echocardiography (TEE)-guided early electrical cardioversion (ECV) persisting nonvalvular atrial fibrillation (AF) without intracardiac clot.
springer.com
sci-hub.se 参考文章(41)
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators, None, A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine. ,vol. 347, pp. 1825- 1833 ,(2002) , 10.1056/NEJMOA021328
Humberto Vidaillet, Robert T Greenlee, Recent progress in the epidemiology of atrial fibrillation. Current Opinion in Cardiology. ,vol. 20, pp. 7- 14 ,(2005)
Fernando Antoñanzas, Transferability of economic evaluation results. PharmacoEconomics. ,vol. 22, pp. 827- 827 ,(2004) , 10.2165/00019053-200422130-00001
S E Coplen, E M Antman, J A Berlin, P Hewitt, T C Chalmers, Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. ,vol. 82, pp. 1106- 1116 ,(1990) , 10.1161/01.CIR.82.4.1106
Ronald L. Wasserstein, Monte Carlo: Concepts, Algorithms, and Applications Technometrics. ,vol. 39, pp. 338- 338 ,(1997) , 10.1080/00401706.1997.10485133
Caroline Schmidt-Lucke, W Dieter Paar, Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, Jürgen Meurer, Rolf Grewe, Werner Günther Daniel, Peter Hanrath, Andreas Mügge, Helmut U Klein, Jan André Schmidt-Lucke, ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group, Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Thrombosis Research. ,vol. 119, pp. 27- 34 ,(2007) , 10.1016/J.THROMRES.2005.11.016
Samuel Lévy, Martine Maarek, Philippe Coumel, Louis Guize, Jean Lekieffre, Jean-Louis Medvedowsky, Alain Sebaoun, Characterization of Different Subsets of Atrial Fibrillation in General Practice in France The ALFA Study Circulation. ,vol. 99, pp. 3028- 3035 ,(1999) , 10.1161/01.CIR.99.23.3028
Stephanie Boulenger, John Nixon, Michael Drummond, Philippe Ulmann, Stephen Rice, Gerard de Pouvourville, Can economic evaluations be made more transferable European Journal of Health Economics. ,vol. 6, pp. 334- 346 ,(2005) , 10.1007/S10198-005-0322-1
MARK M. GALLAGHER, A. JOHN CAMM, Classification of Atrial Fibrillation Pacing and Clinical Electrophysiology. ,vol. 20, pp. 1603- 1605 ,(1997) , 10.1111/J.1540-8159.1997.TB03527.X
Uwe Nixdorff, Antithrombotic strategies for the management of non-valvular atrial fibrillation. International Journal of Cardiology. ,vol. 100, pp. 191- 198 ,(2005) , 10.1016/J.IJCARD.2004.12.030